Dost; Rita

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dost; Rita.The latest application filed is for "triazoles as nr2b receptor inhibitors".

Company Profile

1.11.13

Dost; Rita - Dresden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triazoles as NR2B receptor inhibitors Grant 10,323,021 - Schindler , et al.	2019-06-18
Pyrazoles Grant 10,155,727 - Schindler , et al. Dec	2018-12-18
Triazoles As Nr2b Receptor Inhibitors App 20180282305 - Schindler; Rudolf ; et al.	2018-10-04
Triazoles as NR2B receptor inhibitors Grant 9,981,950 - Schindler , et al. May 29, 2	2018-05-29
Pyrazoles App 20170275254 - Schindler; Rudolf ; et al.	2017-09-28
Triazoles As Nr2b Receptor Inhibitors App 20170226087 - Schindler; Rudolf ; et al.	2017-08-10
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases Grant 9,540,379 - Lankau , et al. January 10, 2	2017-01-10
Use Of Dihydroimidazolones For The Treatment Of Dogs App 20160367562 - RUNDFELDT; Chris ; et al.	2016-12-22
Use of dihydroimidazolones for the treatment of dogs Grant 9,469,611 - Rundfeldt , et al. October 18, 2	2016-10-18
Use Of Dihydroimidazolones For The Treatment Of Dogs App 20150072983 - RUNDFELDT; Chris ; et al.	2015-03-12
Use of dihydroimidazolones for the treatment of dogs Grant 8,962,617 - Rundfeldt , et al. February 24, 2	2015-02-24
Use of dihydroimidazolones for the treatment of dogs Grant 8,859,540 - Rundfeldt , et al. October 14, 2	2014-10-14
Use Of Dihydroimidazolones For The Treatment Of Dogs App 20130065898 - RUNDFELDT; CHRIS ; et al.	2013-03-14
(1,2,4)triazolo[4,3-a]quinoxaline Derivatives As Inhibitors Of Phosphodiesterases App 20120302564 - Lankau; Hans-Joachim ; et al.	2012-11-29
Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor App 20080114032 - Langen; Barbara ; et al.	2008-05-15
Use of dihydroimidazolones for the treatment of dogs App 20080027057 - Rundfeldt; Chris ; et al.	2008-01-31
Use of dihydroimidazolones for the treatment of dogs App 20050070537 - Rundfeldt, Chris ; et al.	2005-03-31
Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor App 20050032863 - Langen, Barbara ; et al.	2005-02-10
2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the same App 20030186997 - Arnold, Thomas ; et al.	2003-10-02
For a process for treatment of anxiety and tension Grant 5,994,347 - Rostock , et al. November 30, 1	1999-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.